Kissing As a Protective Factor Against Acidic PH in Saliva
Launched by UNIVERSIDAD CATOLICA SANTIAGO DE GUAYAQUIL · Jul 9, 2024
Trial Information
Current as of July 04, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The goal of this intervention study will be to determine if oral kissing between two people can increase salivary pH more quickly after drinking artificial juices, soft drinks, or (non-alcoholic) beers. It will also be studied whether the pH restoration time is faster when only one person kisses one of the named drinks or when both people do it. The main questions that are intended to be answered are the following:
* Is the act of kissing on the mouth capable of increasing the pH of saliva more quickly than physiologically after consuming a sugary or fermented drink that has decreased it?
...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • They must be in good health
- • They must have good oral health according to the raised loss and observed index.
- • They will be between 18 and 30 years old to reduce the probability of consuming medications that alter salivary pH.
- Exclusion Criteria:
- • Be taking medications that alter the pH of saliva.
- • Have abscesses in the oral cavity
About Universidad Catolica Santiago De Guayaquil
Universidad Católica Santiago de Guayaquil (UCSG) is a leading institution dedicated to advancing medical research and education in Ecuador. As a clinical trial sponsor, UCSG is committed to fostering innovative healthcare solutions through rigorous scientific investigation and collaboration with healthcare professionals. With a focus on ethical practices and patient safety, UCSG aims to contribute to the development of new therapies and improve health outcomes in the community. The university leverages its academic resources and expertise to support clinical trials that address pressing medical challenges, reinforcing its role as a pivotal player in the region's health research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guayaquil, Guayas, Ecuador
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported